These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20797499)

  • 1. Ranolazine is effective for acute or chronic ischemic dysfunction with heart failure.
    Nanda S; Martinez MW; Dey T
    J Am Coll Cardiol; 2010 Aug; 56(10):822; author reply 822. PubMed ID: 20797499
    [No Abstract]   [Full Text] [Related]  

  • 2. Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias.
    Stone PH
    Cardiol Clin; 2008 Nov; 26(4):603-14. PubMed ID: 18929234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
    Mega JL; Hochman JS; Scirica BM; Murphy SA; Sloan S; McCabe CH; Merlini P; Morrow DA
    Circulation; 2010 Apr; 121(16):1809-17. PubMed ID: 20385930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
    Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Skene A; McCabe CH; Braunwald E;
    Am Heart J; 2006 Jun; 151(6):1186.e1-9. PubMed ID: 16781216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic ischemic heart diseases. Effectively alleviating ischemia symptoms].
    MMW Fortschr Med; 2012 Oct; 154(18):80-1. PubMed ID: 23156882
    [No Abstract]   [Full Text] [Related]  

  • 6. Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
    Nanda S; Levin V; Martinez MW; Freudenberger R
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):e119-20. PubMed ID: 20345626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranolazine in heart failure with preserved left ventricular ejection fraction and microvascular dysfunction: case report and literature review.
    D'Elia E; Fiocca L; Ferrero P; Iacovoni A; Baio P; Medolago G; Duino V; Gori M; Gavazzi A; Senni M
    J Clin Pharmacol; 2013 Jun; 53(6):665-9. PubMed ID: 23585217
    [No Abstract]   [Full Text] [Related]  

  • 11. Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report.
    Murdock DK; Kaliebe J; Overton N
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):765-8. PubMed ID: 18507552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of non-sustained ventricular tachycardia with ranolazine: a case report.
    Kaliebe JW; Murdock DK
    WMJ; 2009 Oct; 108(7):373-5. PubMed ID: 19886587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?
    Cocco G
    Expert Opin Pharmacother; 2012 Dec; 13(17):2429-32. PubMed ID: 23121536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine: a novel agent that improves dysfunctional sodium channels.
    Pham DQ; Mehta M
    Int J Clin Pract; 2007 May; 61(5):864-72. PubMed ID: 17493093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the understanding of the treatment of chronic angina: a 21st century approach-part II.
    Conti CR
    Clin Cardiol; 2008 Jul; 31(7):295-6. PubMed ID: 18636470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relative improvement of the quality of life (interview by Philip Gräzel)].
    Bauersachs J
    MMW Fortschr Med; 2012 Oct; 154(18):81. PubMed ID: 23156883
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ranolazine--new treatment of chronic stable angina pectoris].
    Ahlehoff O; Hansen PR
    Ugeskr Laeger; 2009 Dec; 171(50):3705-7. PubMed ID: 20003868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angina pectoris. Ranolazine is effective in myocardial ischemia therapy].
    MMW Fortschr Med; 2013 Oct; 155(18):74-5. PubMed ID: 24288929
    [No Abstract]   [Full Text] [Related]  

  • 19. Ranolazine: a novel therapeutic option in chronic stable angina.
    Jose J; Jimmy B; Saravu K; Shastry BA
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):596-9. PubMed ID: 18604102
    [No Abstract]   [Full Text] [Related]  

  • 20. Ranolazine for the management of coronary artery disease.
    Cheng JW
    Clin Ther; 2006 Dec; 28(12):1996-2007. PubMed ID: 17296457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.